Cargando…

Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade

BACKGROUND: Breast cancer (BC) is the most common cancer in women in the developed world. In order to find developing cancers in an early stage, BC screening is commonly used. In Flanders, screening is performed in and outside an organized breast cancer screening program (BCSP). However, the determi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, L., Jidkova, S., Greuter, M. J. W., Van Herck, K., Goossens, M., Martens, P., de Bock, G. H., Van Hal, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694412/
https://www.ncbi.nlm.nih.gov/pubmed/33246477
http://dx.doi.org/10.1186/s12939-020-01323-z
_version_ 1783614971493482496
author Ding, L.
Jidkova, S.
Greuter, M. J. W.
Van Herck, K.
Goossens, M.
Martens, P.
de Bock, G. H.
Van Hal, G.
author_facet Ding, L.
Jidkova, S.
Greuter, M. J. W.
Van Herck, K.
Goossens, M.
Martens, P.
de Bock, G. H.
Van Hal, G.
author_sort Ding, L.
collection PubMed
description BACKGROUND: Breast cancer (BC) is the most common cancer in women in the developed world. In order to find developing cancers in an early stage, BC screening is commonly used. In Flanders, screening is performed in and outside an organized breast cancer screening program (BCSP). However, the determinants of BC screening coverage for both screening strategies are yet unknown. OBJECTIVE: To assess the determinants of BC screening coverage in Flanders. METHODS: Reimbursement data were used to attribute a screening status to each woman in the target population for the years 2008–2016. Yearly coverage data were categorized as screening inside or outside BCSP or no screening. Data were clustered by municipality level. A generalized linear equation model was used to assess the determinants of screening type. RESULTS: Over all years and municipalities, the median screening coverage rate inside and outside BCSP was 48.40% (IQR: 41.50–54.40%) and 14.10% (IQR: 9.80–19.80%) respectively. A higher coverage rate outside BSCP was statistically significantly (P < 0.001) associated with more crowded households (OR: 3.797, 95% CI: 3.199–4.508), younger age, higher population densities (OR: 2.528, 95% CI: 2.455–2.606), a lower proportion of unemployed job seekers (OR: 0.641, 95% CI: 0.624–0.658) and lower use of dental care (OR: 0.969, 95% CI: 0.967–0.972). CONCLUSION: Coverage rate of BC screening is not optimal in Flanders. Women with low SES that are characterized by younger age, living in a high population density area, living in crowded households, or having low dental care are less likely to be screened for BC in Flanders. If screened, they are more likely to be screened outside the BCSP.
format Online
Article
Text
id pubmed-7694412
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-76944122020-11-30 Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade Ding, L. Jidkova, S. Greuter, M. J. W. Van Herck, K. Goossens, M. Martens, P. de Bock, G. H. Van Hal, G. Int J Equity Health Research BACKGROUND: Breast cancer (BC) is the most common cancer in women in the developed world. In order to find developing cancers in an early stage, BC screening is commonly used. In Flanders, screening is performed in and outside an organized breast cancer screening program (BCSP). However, the determinants of BC screening coverage for both screening strategies are yet unknown. OBJECTIVE: To assess the determinants of BC screening coverage in Flanders. METHODS: Reimbursement data were used to attribute a screening status to each woman in the target population for the years 2008–2016. Yearly coverage data were categorized as screening inside or outside BCSP or no screening. Data were clustered by municipality level. A generalized linear equation model was used to assess the determinants of screening type. RESULTS: Over all years and municipalities, the median screening coverage rate inside and outside BCSP was 48.40% (IQR: 41.50–54.40%) and 14.10% (IQR: 9.80–19.80%) respectively. A higher coverage rate outside BSCP was statistically significantly (P < 0.001) associated with more crowded households (OR: 3.797, 95% CI: 3.199–4.508), younger age, higher population densities (OR: 2.528, 95% CI: 2.455–2.606), a lower proportion of unemployed job seekers (OR: 0.641, 95% CI: 0.624–0.658) and lower use of dental care (OR: 0.969, 95% CI: 0.967–0.972). CONCLUSION: Coverage rate of BC screening is not optimal in Flanders. Women with low SES that are characterized by younger age, living in a high population density area, living in crowded households, or having low dental care are less likely to be screened for BC in Flanders. If screened, they are more likely to be screened outside the BCSP. BioMed Central 2020-11-27 /pmc/articles/PMC7694412/ /pubmed/33246477 http://dx.doi.org/10.1186/s12939-020-01323-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ding, L.
Jidkova, S.
Greuter, M. J. W.
Van Herck, K.
Goossens, M.
Martens, P.
de Bock, G. H.
Van Hal, G.
Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade
title Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade
title_full Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade
title_fullStr Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade
title_full_unstemmed Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade
title_short Coverage determinants of breast cancer screening in Flanders: an evaluation of the past decade
title_sort coverage determinants of breast cancer screening in flanders: an evaluation of the past decade
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694412/
https://www.ncbi.nlm.nih.gov/pubmed/33246477
http://dx.doi.org/10.1186/s12939-020-01323-z
work_keys_str_mv AT dingl coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade
AT jidkovas coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade
AT greutermjw coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade
AT vanherckk coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade
AT goossensm coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade
AT martensp coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade
AT debockgh coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade
AT vanhalg coveragedeterminantsofbreastcancerscreeninginflandersanevaluationofthepastdecade